Determinants of polymicrobial diabetic wound infections

多种微生物糖尿病伤口感染的决定因素

基本信息

  • 批准号:
    10665269
  • 负责人:
  • 金额:
    $ 23.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-01 至 2025-06-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Group B Streptococcus (GBS), is an opportunistic pathogen that asymptomatically colonizes the urogenital and female reproductive tract of approximately 25-30% of individuals. However, GBS can cause serious infections in immunocompromised individuals including those with diabetes. Diabetic wound infections are a major public health burden, with approximately 25% of diabetic individuals developing a wound in their lifetime, 25% of these wounds not healing and 28% requiring surgical amputation. Poor infection outcomes are correlated with the presence of numerous bacterial pathogens, and GBS, along with Staphylococcus aureus, is one of the most common bacteria found in these wounds. Despite its prevalence, no prior work has been done on GBS pathogenesis in the diabetic wound environment. Recently, we developed a Type 2 diabetic murine model of GBS diabetic wound infection in leprdb mice, and demonstrated that GBS forms a robust wound and persists in this environment. Further observations found that GBS colonies recovered from diabetic wound tissue were hyper-pigmented/hemolytic, suggesting selection of more virulent GBS mutants during diabetic infection. These phenotypes mimic those of a covR mutant, as CovR is a major repressor of GBS virulence factors such as the GBS hemolysin/pigment, nuclease (NucA), and surface adhesin plasminogen binding protein PbsP. Dual RNA-sequencing of GBS and the murine wound revealed that these same CovR regulated genes were highly upregulated in the diabetic wound. In addition, GBS infection triggered the recruitment of neutrophils, neutrophil activation and NET formation at the site of infection. Finally, we have shown in our murine model that the presence of S. aureus promotes GBS persistence in the diabetic wound. With these preliminary data, we have formulated hypotheses which address multiple mechanisms by which GBS may survive and persist in the diabetic wound environment. These hypotheses will be addressed in the following specific aims: Aim 1: Determine how CovR regulation contributes to diabetic wound infection, Aim 2: Characterize the contribution of PbsP to GBS diabetic wound formation, persistence, and dissemination, Aim 3: Examine the contribution of nuclease activity in promoting GBS immune evasion and wound persistence. These studies will increase our understanding of the pathogenesis of GBS diabetic wound infection and will provide a platform for additional studies.
项目摘要 B族链球菌(GBS)是一种机会致病菌,其无症状地定殖于泌尿生殖道, 女性生殖道约占25-30%。然而,GBS可导致严重的感染 免疫功能低下的个体,包括糖尿病患者。糖尿病伤口感染是主要的公众 健康负担,大约25%的糖尿病患者在其一生中会出现伤口,其中25% 伤口不愈合,28%需要手术截肢。不良感染结果与 许多细菌病原体的存在,GBS,沿着金黄色葡萄球菌,是最常见的病原体之一。 这些伤口中常见的细菌尽管它的流行,没有先前的工作已经做了GBS 糖尿病伤口环境中的发病机制。最近,我们开发了一种2型糖尿病小鼠模型, GBS糖尿病伤口感染leprdb小鼠,并证明GBS形成一个强大的伤口,并持续存在, 这种环境。进一步的观察发现,从糖尿病伤口组织中回收的GBS集落是 色素沉着过度/溶血,表明在糖尿病感染期间选择了毒性更强的GBS突变体。 这些表型模拟covR突变体的表型,因为CovR是GBS毒力因子的主要阻遏物, 如GBS溶血素/色素、核酸酶(NucA)和表面粘附素纤溶酶原结合蛋白PbsP。双 GBS和小鼠伤口的RNA测序显示,这些相同的CovR调节基因在GBS和小鼠伤口中高度表达。 在糖尿病伤口中表达上调。此外,GBS感染触发了中性粒细胞的募集, 在感染部位的活化和NET形成。最后,我们在小鼠模型中表明, S的存在。金黄色葡萄球菌促进GBS在糖尿病伤口中的持久性。根据这些初步数据,我们有 制定的假设,解决多种机制,其中GBS可能生存和坚持在 糖尿病伤口环境。这些假设将在以下具体目标中得到解决:目标1: 确定CovR调节如何促进糖尿病伤口感染,目的2:表征 PbsP对GBS糖尿病伤口形成、持久性和播散的贡献,目的3:检查 核酸酶活性在促进GBS免疫逃避和创伤持久性中的作用。这些 这些研究将增加我们对GBS糖尿病伤口感染发病机制的了解, 平台进行更多的研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kelly S Doran其他文献

Kelly S Doran的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kelly S Doran', 18)}}的其他基金

Colorado Immunology and Microbiology Conference (CIMC)
科罗拉多州免疫学和微生物学会议(CIMC)
  • 批准号:
    10751556
  • 财政年份:
    2023
  • 资助金额:
    $ 23.33万
  • 项目类别:
Roles of novel cationic lipids in bacterial pathogenesis
新型阳离子脂质在细菌发病机制中的作用
  • 批准号:
    10732462
  • 财政年份:
    2023
  • 资助金额:
    $ 23.33万
  • 项目类别:
2022 Streptococcal Biology Gordon Research Conference and Gordon Research Seminar
2022年链球菌生物学戈登研究大会暨戈登研究研讨会
  • 批准号:
    10462952
  • 财政年份:
    2022
  • 资助金额:
    $ 23.33万
  • 项目类别:
Calprotectin modulates Group B streptococcal colonization and disease
钙卫蛋白调节 B 族链球菌定植和疾病
  • 批准号:
    10190492
  • 财政年份:
    2021
  • 资助金额:
    $ 23.33万
  • 项目类别:
Host and bacterial mechanisms governing Group B streptococcal persistence in the female genital tract
控制 B 族链球菌在女性生殖道中持续存在的宿主和细菌机制
  • 批准号:
    10219491
  • 财政年份:
    2021
  • 资助金额:
    $ 23.33万
  • 项目类别:
Calprotectin modulates Group B streptococcal colonization and disease
钙卫蛋白调节 B 族链球菌定植和疾病
  • 批准号:
    10373060
  • 财政年份:
    2021
  • 资助金额:
    $ 23.33万
  • 项目类别:
Host and bacterial mechanisms governing Group B streptococcal persistence in the female genital tract
控制 B 族链球菌在女性生殖道中持续存在的宿主和细菌机制
  • 批准号:
    10363740
  • 财政年份:
    2021
  • 资助金额:
    $ 23.33万
  • 项目类别:
Host and bacterial mechanisms governing Group B streptococcal persistence in the female genital tract
控制 B 族链球菌在女性生殖道中持续存在的宿主和细菌机制
  • 批准号:
    10754833
  • 财政年份:
    2021
  • 资助金额:
    $ 23.33万
  • 项目类别:
Host and bacterial mechanisms governing Group B streptococcal persistence in the female genital tract
控制 B 族链球菌在女性生殖道中持续存在的宿主和细菌机制
  • 批准号:
    10763095
  • 财政年份:
    2021
  • 资助金额:
    $ 23.33万
  • 项目类别:
Host and bacterial mechanisms governing Group B streptococcal persistence in the female genital tract
控制 B 族链球菌在女性生殖道中持续存在的宿主和细菌机制
  • 批准号:
    10569009
  • 财政年份:
    2021
  • 资助金额:
    $ 23.33万
  • 项目类别:

相似海外基金

Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
  • 批准号:
    10568717
  • 财政年份:
    2023
  • 资助金额:
    $ 23.33万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10419967
  • 财政年份:
    2022
  • 资助金额:
    $ 23.33万
  • 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
  • 批准号:
    10592441
  • 财政年份:
    2022
  • 资助金额:
    $ 23.33万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10369750
  • 财政年份:
    2021
  • 资助金额:
    $ 23.33万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10633248
  • 财政年份:
    2021
  • 资助金额:
    $ 23.33万
  • 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
  • 批准号:
    10487516
  • 财政年份:
    2021
  • 资助金额:
    $ 23.33万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    10228564
  • 财政年份:
    2018
  • 资助金额:
    $ 23.33万
  • 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
  • 批准号:
    9347041
  • 财政年份:
    2017
  • 资助金额:
    $ 23.33万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9480702
  • 财政年份:
    2016
  • 资助金额:
    $ 23.33万
  • 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
  • 批准号:
    9906853
  • 财政年份:
    2016
  • 资助金额:
    $ 23.33万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了